The soluble form of the receptor of advanced glycation endproducts increases after bariatric surgery in morbid obesity (Q84614488)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22828946%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

title

The soluble form of the receptor of advanced glycation endproducts increases after bariatric surgery in morbid obesity (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22828946%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

1 reference

J M Brix

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22828946%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

F Höllerl

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22828946%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

H-P Kopp

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22828946%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

G H Schernthaner

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22828946%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

G Schernthaner

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22828946%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

publication date

17 July 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22828946%20AND%20SRC:MED&resulttype=core&format=json

International Journal of Obesity

8 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22828946%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

volume

36

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22828946%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

issue

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22828946%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

page(s)

1412-1417

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22828946%20AND%20SRC:MED&resulttype=core&format=json

Advanced glycation end-products: a review

8 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2012.107

7 January 2021

RAGE is a multiligand receptor of the immunoglobulin superfamily: implications for homeostasis and chronic disease

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2012.107

7 January 2021

Advanced Glycation End Products Activate Endothelium Through Signal-Transduction Receptor RAGE

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2012.107

7 January 2021

Association between circulating soluble receptor for advanced glycation end products and atherosclerosis: observations from the Dallas Heart Study.

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2012.107

7 January 2021

Plasma sRAGE is independently associated with urinary albumin excretion in type 2 diabetes

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2012.107

7 January 2021

Plasma levels of soluble receptor for advanced glycation end products and coronary artery disease in nondiabetic men.

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2012.107

7 January 2021

Novel splice variants of the receptor for advanced glycation end-products expressed in human vascular endothelial cells and pericytes, and their putative roles in diabetes-induced vascular injury

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2012.107

7 January 2021

A soluble form of the receptor for advanced glycation endproducts (RAGE) is produced by proteolytic cleavage of the membrane-bound form by the sheddase a disintegrin and metalloprotease 10 (ADAM10)

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2012.107

7 January 2021

Multiple levels of regulation determine the role of the receptor for AGE (RAGE) as common soil in inflammation, immune responses and diabetes mellitus and its complications

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2012.107

7 January 2021

Decreased plasma levels of soluble receptor for advanced glycation end-products in patients with essential hypertension.

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2012.107

7 January 2021

Serum endogenous secretory RAGE level is an independent risk factor for the progression of carotid atherosclerosis in type 1 diabetes

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2012.107

7 January 2021

Decreased plasma soluble RAGE in patients with hypercholesterolemia: effects of statins

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2012.107

7 January 2021

Circulating levels of soluble receptor for advanced glycation end products in Alzheimer disease and vascular dementia.

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2012.107

7 January 2021

Decreased plasma levels of soluble receptor for advanced glycation endproducts (sRAGE) in patients with nonalcoholic fatty liver disease.

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2012.107

7 January 2021

Circulating soluble receptor for advanced glycation end products is inversely associated with glycemic control and S100A12 protein.

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2012.107

7 January 2021

High levels of soluble receptor for advanced glycation end products may be a marker of extreme longevity in humans.

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2012.107

7 January 2021

Circulating soluble receptor for advanced glycation end products is inversely associated with body mass index and waist/hip ratio in the general population

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2012.107

7 January 2021

Positive association between serum levels of advanced glycation end products and the soluble form of receptor for advanced glycation end products in nondiabetic subjects.

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2012.107

7 January 2021

Independent determinants of soluble form of receptor for advanced glycation end products in elderly hypertensive patients

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2012.107

7 January 2021

Total soluble and endogenous secretory receptor for advanced glycation end products as predictive biomarkers of coronary heart disease risk in patients with type 2 diabetes: an analysis from the CARDS trial

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2012.107

7 January 2021

Enhanced expression of receptor for advanced glycation end-products is associated with low circulating soluble isoforms of the receptor in Type 2 diabetes

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2012.107

7 January 2021

Relationship of androgens to insulin resistance and chronic inflammation in morbidly obese premenopausal women: studies before and after vertical banded gastroplasty.

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2012.107

7 January 2021

Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2012.107

7 January 2021

Power and sample size calculations. A review and computer program

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2012.107

7 January 2021

Advanced glycation end products and vascular inflammation: implications for accelerated atherosclerosis in diabetes.

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2012.107

7 January 2021

Purification and characterization of mouse soluble receptor for advanced glycation end products (sRAGE)

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2012.107

7 January 2021

RAGE blockade stabilizes established atherosclerosis in diabetic apolipoprotein E-null mice.

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2012.107

7 January 2021

Circulating soluble receptor of advanced glycation end product inversely correlates with atherosclerosis in patients with chronic kidney disease

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2012.107

7 January 2021

Plasma levels of soluble receptor for advanced glycation end products are associated with endothelial function and predict cardiovascular events in nondiabetic patients

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2012.107

7 January 2021

Etiologic diagnosis of ischemic stroke subtypes with plasma biomarkers.

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2012.107

7 January 2021

Low levels of plasma soluble receptor for advanced glycation end products are associated with severe leukoaraiosis in acute stroke patients

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2012.107

7 January 2021

Association of serum soluble receptor for advanced glycation end-products with subclinical cerebrovascular disease: the Northern Manhattan Study (NOMAS)

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2012.107

7 January 2021

Levels of soluble receptor for AGE are cross-sectionally associated with cardiovascular disease in type 1 diabetes, and this association is partially mediated by endothelial and renal dysfunction and by low-grade inflammation: the EURODIAB Prospectiv

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2012.107

7 January 2021

Effects of atorvastatin on serum soluble receptors for advanced glycation end-products in type 2 diabetes

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2012.107

7 January 2021

Thiazolidinedione increases serum soluble receptor for advanced glycation end-products in type 2 diabetes

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2012.107

7 January 2021

Cancer incidence and mortality after gastric bypass surgery

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2012.107

7 January 2021

Effects of bariatric surgery on cancer incidence in obese patients in Sweden (Swedish Obese Subjects Study): a prospective, controlled intervention trial

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2012.107

7 January 2021

Evidence that serum levels of the soluble receptor for advanced glycation end products are inversely associated with pancreatic cancer risk: a prospective study

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2012.107

7 January 2021

Plasma level of endogenous secretory RAGE is associated with components of the metabolic syndrome and atherosclerosis

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2012.107

7 January 2021

Effects of Bariatric Surgery on Mortality in Swedish Obese Subjects

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2012.107

7 January 2021